Kavar Capital Partners Group LLC Sells 436 Shares of The Procter & Gamble Company (NYSE:PG)

Kavar Capital Partners Group LLC cut its holdings in The Procter & Gamble Company (NYSE:PGGet Rating) by 0.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 63,172 shares of the company’s stock after selling 436 shares during the quarter. Procter & Gamble comprises 2.2% of Kavar Capital Partners Group LLC’s holdings, making the stock its 11th biggest position. Kavar Capital Partners Group LLC’s holdings in Procter & Gamble were worth $9,574,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Capital Investment Advisory Services LLC increased its position in Procter & Gamble by 4.9% during the 4th quarter. Capital Investment Advisory Services LLC now owns 36,681 shares of the company’s stock worth $5,559,000 after buying an additional 1,711 shares during the period. Deuterium Capital Management LLC acquired a new stake in Procter & Gamble in the fourth quarter valued at about $675,000. CX Institutional boosted its stake in shares of Procter & Gamble by 4.1% during the fourth quarter. CX Institutional now owns 33,743 shares of the company’s stock valued at $5,114,000 after purchasing an additional 1,320 shares in the last quarter. Oak Harbor Wealth Partners LLC boosted its stake in shares of Procter & Gamble by 11.1% during the fourth quarter. Oak Harbor Wealth Partners LLC now owns 30,891 shares of the company’s stock valued at $4,682,000 after purchasing an additional 3,089 shares in the last quarter. Finally, Blue Chip Partners LLC boosted its stake in shares of Procter & Gamble by 1.9% during the fourth quarter. Blue Chip Partners LLC now owns 21,503 shares of the company’s stock valued at $3,259,000 after purchasing an additional 409 shares in the last quarter. 62.13% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Trading Down 0.2 %

PG stock traded down $0.33 during trading on Friday, hitting $145.06. 2,277,418 shares of the company traded hands, compared to its average volume of 6,383,554. The firm has a market capitalization of $341.90 billion, a PE ratio of 25.31, a P/E/G ratio of 4.07 and a beta of 0.41. The Procter & Gamble Company has a 1 year low of $122.18 and a 1 year high of $158.11. The company has a 50-day moving average of $151.37 and a 200-day moving average of $147.02. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.39 and a current ratio of 0.59.

Procter & Gamble (NYSE:PGGet Rating) last released its quarterly earnings data on Friday, April 21st. The company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.32 by $0.05. Procter & Gamble had a return on equity of 32.18% and a net margin of 17.69%. The business had revenue of $20.07 billion during the quarter, compared to analysts’ expectations of $19.32 billion. During the same quarter last year, the business posted $1.33 EPS. The business’s revenue was up 3.5% on a year-over-year basis. Analysts predict that The Procter & Gamble Company will post 5.86 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, May 15th. Shareholders of record on Friday, April 21st were paid a dividend of $0.9407 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.91. The ex-dividend date of this dividend was Thursday, April 20th. This represents a $3.76 dividend on an annualized basis and a yield of 2.59%. Procter & Gamble’s payout ratio is presently 65.51%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. StockNews.com assumed coverage on Procter & Gamble in a report on Thursday, May 18th. They issued a “buy” rating for the company. Raymond James raised their price objective on Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Sunday, April 23rd. Morgan Stanley raised their price objective on Procter & Gamble from $160.00 to $174.00 and gave the company an “overweight” rating in a research note on Monday, April 24th. Truist Financial cut Procter & Gamble from a “buy” rating to a “hold” rating and cut their target price for the company from $165.00 to $155.00 in a research report on Thursday, May 18th. Finally, Barclays lifted their target price on Procter & Gamble from $160.00 to $167.00 in a research report on Wednesday, April 26th. Five analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $161.50.

Insider Transactions at Procter & Gamble

In related news, COO Shailesh Jejurikar sold 31,000 shares of Procter & Gamble stock in a transaction on Monday, May 1st. The stock was sold at an average price of $156.03, for a total value of $4,836,930.00. Following the completion of the sale, the chief operating officer now owns 10,014 shares of the company’s stock, valued at $1,562,484.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, COO Shailesh Jejurikar sold 31,000 shares of Procter & Gamble stock in a transaction on Monday, May 1st. The stock was sold at an average price of $156.03, for a total value of $4,836,930.00. Following the completion of the sale, the chief operating officer now owns 10,014 shares of the company’s stock, valued at $1,562,484.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Susan Street Whaley sold 709 shares of the business’s stock in a transaction dated Wednesday, March 1st. The shares were sold at an average price of $137.34, for a total value of $97,374.06. Following the sale, the insider now directly owns 10,198 shares of the company’s stock, valued at approximately $1,400,593.32. The disclosure for this sale can be found here. Insiders sold 99,424 shares of company stock worth $15,416,750 over the last quarter. 0.26% of the stock is currently owned by insiders.

Procter & Gamble Company Profile

(Get Rating)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGGet Rating).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.